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Abstract
The 29,39-cyclic nucleotide 39-phosphodiesterase (CNPase) is a highly abundant membrane-associated enzyme in the myelin
sheath of the vertebrate nervous system. CNPase is a member of the 2H phosphoesterase family and catalyzes the
formation of 29-nucleotide products from 29,39-cyclic substrates; however, its physiological substrate and function remain
unknown. It is likely that CNPase participates in RNA metabolism in the myelinating cell. We solved crystal structures of the
phosphodiesterase domain of mouse CNPase, showing the binding mode of nucleotide ligands in the active site. The
binding mode of the product 29-AMP provides a detailed view of the reaction mechanism. Comparisons of CNPase crystal
structures highlight flexible loops, which could play roles in substrate recognition; large differences in the active-site vicinity
are observed when comparing more distant members of the 2H family. We also studied the full-length CNPase, showing its
N-terminal domain is involved in RNA binding and dimerization. Our results provide a detailed picture of the CNPase active
site during its catalytic cycle, and suggest a specific function for the previously uncharacterized N-terminal domain.
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Introduction
The myelin sheath is a crucial component of the vertebrate
nervous system, speeding up nerve impulses and supporting axonal
integrity. The multilayered myelin membrane is rich in lipids and
low in water, with a number of myelin-specific proteins. 29,39-
cyclic nucleotide 39-phosphodiesterase (CNPase), one of the
proteins predominantly expressed in the myelin sheath, represents
4% of total protein in central nervous system myelin [1]. It is
localized in the non-compacted regions of myelin, where it is a
quantitatively major protein. CNPase has been implicated as an
autoantigen in multiple sclerosis [2,3], and mice deficient in
CNPase suffer progressive axonal degeneration leading to
premature death [4].
CNPase belongs to the 2H phosphoesterase superfamily [5,6],
which is characterized by the presence of two conserved HxT/Sx
motifs (x denoting a hydrophobic residue) in the active site. The
2H family members exhibit a 39-phosphodiesterase activity
towards 29,39-cyclic nucleotides, oligonucleotides, or RNA. The
2H phosphoesterases have large sequence variations, but the core
fold and the active site residues are conserved [6].
CNPase contains an N-terminal domain very distantly related to
P-loop containing nucleoside triphosphate hydrolases [7,8] and a
C-terminal phosphodiesterase domain [9]. The N-terminal
domain is poorly characterized, and its function is unknown to
date. Structural data exist for the phosphodiesterase domain from
different species [5,10,11], but no structures have been solved for
2H phosphoesterases complexed with substrates or products, or for
full-length CNPase. At its very C-terminus, CNPase has an
isoprenylation site, linking the protein to the membrane [12].
Thus, the active site of CNPase lies very close to the membrane
surface.
Even 50 years after its initial characterization [13], CNPase is
enigmatic with regard to its physiological function. During recent
years, possible functions have, little by little, been elucidated. The
properties of CNPase, including membrane attachment [14],
interactions with cytoskeletal proteins [15–17], and binding to
RNA [18], have implied that CNPase could be involved in RNA
trafficking, splicing, or metabolism in the myelinating glial cell.
CNPase has also been suggested to regulate the maturation of
oligodendrocytes and the expression of myelin genes [19]. For
example, mRNA for the major myelin protein MBP is transported
to oligodendrocyte processes [20], and CNPase could play a role
in its processing or degradation.
Based on its activity and homology to other enzymes, CNPase
might function in RNA splicing. When an intron is spliced from
immature tRNA, a 29,39-cyclic phosphate group is formed [21]. In
yeast, the subsequent ligation is performed by a single multifunc-
tional tRNA ligase, Trl1. Trl1 contains CNPase activity to heal the
cyclic nucleotide, polynucleotide kinase activity to phosphorylate
the 59-OH group of the 39-exon with phosphate from GTP, and
ATP-dependent ligase activity to seal the exons [22,23]. In yeast,
Trl1 is necessary for complete tRNA splicing and, thus, essential
for the cells [24]. Rat CNPase is able to complement the
phosphodiesterase, but not kinase, activity of yeast Trl1 [25].
Thus, CNPase is able to act as a functional entity in the yeast
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32336tRNA splicing mechanim, but its possible role in the correspond-
ing mechanism in vertebrates in unclear.
In this study, crystal and solution structures of the CNPase
catalytic domain were solved in the presence of active site ligands.
The structural data can be used to elucidate the fine details of the
enzymatic phosphodiesterase activity in CNPase. We also provide
data on the possible functions of the CNPase N-terminal domain.
Results and Discussion
Overall structure of mouse CNPase catalytic domain
We solved the crystal structure of the C-terminal catalytic
phosphodiesterase domain of mouse CNPase in the presence of
active-site ligands, including reaction products (Table 1,2).
Remarkably, no crystal structures of 2H phosphoesterases with
bound substrates or products have been reported earlier.
The overall structure can be divided into two lobes, between
which the active-site cleft is located (Figure 1A). The small lobe
contains both the N- and C-termini in close proximity, and is
comprised of four b strands, three short helices, and a flexible loop
between residues 290 and 308 (a6-b5 loop). The large lobe
contains six antiparallel strands, two long and two short helices,
and three long loops (a2-a3, a3-b2, a7-b6). Differences between
the crystal structures of murine CNPase obtained in this work are
found in these flexible loops (Figure 1B).
The CNPase active site
The active site of CNPase contains two HxTx motifs at residues
230–233 and 309–312, at the bottom of a narrow cleft between the
two lobes (Figure 2). This cleft is enveloped from one side by
Pro320, Val321, and Arg307 and from the other side by Phe235,
Leu167, and Tyr168. Conserved ordered water molecules are
present in the active site (Figure 2A), which we number as waters
1–5 for clarity and consistency. Waters 1–4 line the bottom of the
active site cleft, while water 5 was suggested to be a nucleophilic
water in the reaction mechanism [11]. Interestingly, the strands b2
and b5, on which the HxTx motifs lie, do not interact through
direct backbone hydrogen bonds; instead, the conserved water
molecules 1–4 mediate hydrogen bonds between the two adjacent
strands. This arrangement may bring additional flexibility to the
core of the active site.
The core catalytic site, with the two HxTx motifs and 4 water
molecules, has a pseudo-twofold symmetry (Figure 2A). However,
the symmetry does not extend beyond this region, and substrate
recognition is asymmetric. This is important for CNPase
specificity, selectively cleaving the 39-phosphodiester bond from
29,39-cyclic substrates.
No structural information has been available for nucleotide
complexes of CNPase or its closest homologues. NMR studies on
RICH [10] and CNPase [5] have indicated roles for Phe235 and
Val321 – and its nearby residues at the N-terminus of helix a7-i n
recognition of the nucleotide, while the phosphate complex [11]
indicated the position of catalysis. The detailed binding modes of
nucleotide ligands have not been elucidated. Here, we determined
crystal structures of CNPase with 4 different active-site ligands
(Figure 2), including 29-AMP, NADP
+, sulphate, and citrate; 29-
AMP and NADP
+ are reaction products formed during the
experiment from the respective 29,39-cyclic substrates. With the
combination of these structural data, we can now get a much
deeper insight into catalysis by CNPase than previously possible.
Binding mode of reaction products
Two structures were solved in the presence of a reaction
product in the active site; they resulted from soaking the crystals in
excess of the in vitro substrates 29,39-cAMP and 29,39-cNADP
+.I n
both structures, the cyclic bond has been cleaved, and a 29-product
is located in the active site (Figure 2B,C, Figure S1); the nucleotide
occupies a similar position in both structures. The treatment with
29,39-cAMP resulted in a well-defined molecule of 29-AMP in the
active site. The crystal soaked in 29,39-cNADP
+ indicated a lower
occupancy of the reaction product NADP
+ in the active site; the
29-AMP moiety and the 59-phosphate were, however, visible in the
electron density. The 29-AMP complex will be mainly discussed
here, due to its high occupancy and strong electron density.
The 29-AMP is tightly bound in the narrow active-site cavity.
The adenine base makes stacked p-p interactions with the side
chain of Phe235, while both of its rings are involved in CH-p
hydrogen bonds with Val321 (Figure 2B). The ribose moiety
interacts with CNPase mainly through van der Waals interactions
to Pro320, Val321, and Tyr168. The 39-OH group (the leaving
group in the phosphodiesterase reaction) is H-bonded to the Ne2
atom of His230. A H-bond also exists between the side chain
hydroxyl of Thr232 and the phosphoester oxygen.
Most polar interactions between 29-AMP and the active site are
mediated by the phosphate group (Figure 2B). Two of its oxygen
atoms are coordinated by water molecules 2 and 3 at the center of
the active site; one of these oxygens is also H-bonded to Thr311
and the other one to His309. The third free oxygen of the
phosphate is in van der Waals contact with the backbone carbonyl
group of Pro320 – the geometry is suboptimal for hydrogen
bonding. It is also H-bonded to the Ne2 atom of His309. This is
most likely the position of the nucleophilic water prior to the
reaction, and corresponds to the location of a water molecule
(water 5) in other structures. The 29-nucleotide being a mimic of
Table 1. Crystallization conditions and treatments.
Crystal form Well solution Additives Soaking details Cryoprotection
Orthorhombic
citrate complex
0.1 M sodium citrate
pH 3.9, 26% PEG 3350
10 mM
29,39-cAMP
- 0.1 M sodium citrate pH 3.5, 25% PEG 3350,
20% glycerol, 10 mM 29,39-cAMP
Monoclinic
citrate complex
0.1 M sodium citrate
pH 3.3, 26% PEG 3350
10 mM
29,39-cNADP
- 0.1 M sodium citrate pH 3.5, 25% PEG 3350,
20% glycerol, 10 mM 29,39-cNADP
+
Sulphate
complex
50 mM sodium citrate pH 3.5, 2.9 M
(NH4)2SO4, 10% PEG 550 MME
-- -
29-AMP
complex
50 mM sodium citrate pH 3.5,
30% PEG 3000
- 50 mM sodium citrate pH 3.5, 35%
PEG 1500, 100 mM 29,39-cAMP (4 h)
-
NADP
+
complex
50 mM sodium citrate pH 3.5,
30% PEG 3000
- 50 mM sodium citrate pH 3.5, 35%
PEG 1500, 100 mM 29,39- cNADP
+ (25 min)
-
doi:10.1371/journal.pone.0032336.t001
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entrance by the RNA molecule can be inferred from the binding
mode of the nucleotide (see below).
In the NADP
+ complex, residues 319–321 of CNPase are in a
double conformation related to ligand binding (Figure 2C). These
residues are at the N-terminus of the a7 helix, and this long helix
provides a positive electrostatic environment in the vicinity of the
active site through its helix dipole moment. A role for the flexibility
of the N-terminus of helix a7 has also been indicated by the fact
that a G324A mutation in rat CNPase affects both substrate
binding and catalytic efficiency [5]. The first conformation is
present in all of the structures. We believe this conformation to be
linked to ligand binding. In the second conformation, Pro320 is
moved away, and the nucleophilic water is present. Residue 320 is
not conserved between species, but its carbonyl group, interacting
with the nucleophilic water and the product phosphate, is
apparently important. Val321 and Phe235 sandwich the nucleo-
tide base, and Pro320 interacts with the active site ligands and the
nucleophilic water. Kozlov et al. reported chemical shift pertur-
bations in residues Val321-Gly324 upon ligand binding [5]. It is
likely that this conformational flexibility of the N-terminus of helix
a7 is related to the reaction cycle of the enzyme.
Complexes with sulphate and citrate
In CNPase crystallized in concentrated ammonium sulphate,
two sulphate molecules are located in the vicinity of the catalytic
site. The active-site sulphate mimics the substrate phosphate group
and interacts with all 4 conserved residues of the two HxTx motifs
and the two central water molecules in the catalytic site through
H-bonds (Figure 2D), being also in contact with the backbone
carbonyl of Pro320 and bulk solvent. The second sulphate
stabilizes the long a6-b5 loop. Arg307, between the two sulphate
binding sites, adopts a different conformation in the sulphate
complex, turning away from the active site. The significance of the
a6-b5 loop is not known, but the detection of a sulphate-binding
site and the different conformations seen for the loop suggest it
could be relevant in CNPase function.
Table 2. Data processing and structure refinement.
Dataset
Active site ligand Citrate Citrate Sulphate NADP
+ 29-AMP
PDB entry 2xmi 2y1p 2y3x 2ydb 2ydd
Data collection
and processing:
Beamline BESSY
BL 14.1
BESSY
BL 14.1
BESSY
BL 14.1
MAX-LAB I911-2 MAX-LAB I911-2
Wavelength (A ˚) 0.91841 0.91841 0.91841 1.03796 1.03796
Unit-cell parameters (A ˚) a=41.6b=47.1
c=107.1
a=42.0 b=46.9
c=54.9
a=b=82.4
c=86.3
a=41.7 b=46.8
c=106.9
a=41.4 b=46.8
c=106.6
(u) a=b=c=90 a=c=90b=95.5 a=b=90c=120 a=b=c=90 a=b=c=90
Space group P212121 P21 P31 P212121 P212121
Resolution range (A ˚)* 35–1.74 (1.79–1.74) 26–1.82 (1.87–1.82) 35–2.1 (2.15–2.10) 25–2.15 (2.21–2.15) 20–2.4 (2.46–2.40)
Observed/unique reflections 154941/22280 71653/19148 147089/38236 32782/11501 39972/8420
Rsym (%) 6.6 (94.0) 7.1 (67.5) 4.1 (55.7) 5.0 (41.6) 9.9 (93.9)
,I/sI. 17.7 (2.1) 14.2 (2.0) 20.0 (2.5) 13.2 (2.5) 13.0 (1.8)
Completeness (%) 99.9 (99.7) 99.7 (99.7) 99.8 (99.8) 96.2 (90.2) 98.2 (99.5)
Redundancy 7.0 (6.1) 3.7 (3.7) 3.9 (3.8) 2.9 (2.4) 4.7 (4.8)
Refinement:
Rcryst (%) 17.8 15.8 19.0 19.7 20.7
Rfree (%) 20.9 19.9 22.8 25.6 26.9
Wilson B factor (A ˚2) 31.4 27.7 49.3 43.5 45.3
Average B factor (A ˚2) 36.5 39.0 72.0 50.0 68.5
R.m.s.d. bond length (A ˚) 0.006 0.009 0.015 0.006 0.010
R.m.s.d. bond angle (u) 0.9 1.1 1.6 1.0 1.3
Missing residues 158–159, 210–212 158–160 A: 158–163, B: 158–159,
209–212, C: 158–163. 208–212
158–162, 209–211 158–162, 207–212
Molprobity analysis:
Clashscore (percentile) 7.3 (85th) 12.5 (61st) 9.3 (88th) 11.9 (79th) 3.6 (99th)
Ramachandran plot
Favoured (%) 99.5 96.8 98.3 97.6 97.6
Disallowed (%) 0.0 0.0 0.0 0.0 0.0
Molprobity score (percentile) 1.40 (95th) 1.81 (78th) 1.84 (89th) 2.02 (82nd) 1.78 (97th)
*numbers in parentheses correspond to the highest-resolution shell.
doi:10.1371/journal.pone.0032336.t002
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the highest resolutions. The primary interaction of the citrate with
the active site comes from the central carboxyl group, bound to
His230 and Thr232 (Figure 2A). The nucleophilic water 5 is
bound to the central and terminal carboxyl groups of citrate and to
His309 and the carbonyl oxygen of Pro320.
Comparison to homologous structures
The structurally characterized members of the 2H phosphoes-
terase family can be divided into two groups (Table 3, Figure S2).
The first group contains mammalian CNPases and goldfish
RICH. The more distant group contains bacterial and archaeal
29-59 RNA ligases [26–28], a plant cyclic nucleotide phosphodi-
esterase (CPDase) [29], and a human protein kinase A anchoring
protein (AKAP18) [30].
The core structure of the mouse CNPase catalytic domain is
very similar to the human enzyme and RICH [10,11]. The largest
difference between the mouse and human CNPase is in the a6-b5
loop; this is also a region of least sequence conservation between
the two species. The rat CNPase NMR solution structure also
shows most differences in the loops; in addition, helix a7i si na
slightly different orientation compared to the crystal structures,
opening up the active site (Figure 3A).
Also in more distant family members, the essential active site
residues are similarly located. The catalytic cleft, symmetrically
formed on top of antiparallel strands, is structured in a similar
fashion. The long helix a1 is similar in all compared structures.
There are, however, interesting differences - possibly affecting
substrate binding - between CNPases/RICH and the other 2H
phosphoesterases.
A major difference is that the long helix a7 is not conserved in
non-CNPase structures (Figure 3B, Figure S2). The N-terminus of
the a7 helix borders the CNPase active site, interacts closely with
the substrate and the nucleophilic water, and effectively blocks the
entrance of large molecules from this direction. The absence of a7
may create a binding pocket for large substrates in some of the
other RNA-processing enzymes within the family, and it is possible
that these enzymes also have differences in their respective
catalytic mechanisms.
Another major difference is the presence of a covering region on
the opposite side of the active site in non-CNPase structures
(Figure 3B). This cover is formed by a b-hairpin segment, which in
sequence alignments, is located after the C-terminal end of the
CNPase folded domain (Figure S2).
Taken together, the CNPase active site cleft is more open
towards the His230 side of the cleft, as opposed to the 29-59 RNA
ligase, CPDase, and AKAP18, which are more open towards the
His309 side. The crystal structure of the 2H family domain of
AKAP18 has been solved with bound 59-AMP and 59-CMP,
although no enzymatic activity has been observed [30].
Correlating with the differences outlined above, the active-site
nucleotide binding modes in AKAP18 and CNPase are distinct,
with the phosphate group being bound to the HxTx motifs in
both proteins (Figure 3B). The results further indicate that in 2H
family members, the ligand binding mode is conserved only for
the reactive phosphate moiety, and arrangements around the
active site in the protein, concerning both secondary structure
elements and flexible loops, significantly affect the actual binding
mode of the full substrate, further having effects on reaction
specficity.
Figure 1. The overall structure. (a) Crystal structure of the mouse CNPase phosphodiesterase domain. The side chains of the conserved HxTx
motifs and the bound 29-AMP in the active site are shown as sticks. The protein is colored from blue (N-terminus) to red (C-terminus), and secondary
structure elements are labelled. (b) Superposition of the three different crystal forms of mouse CNPase determined in this study, indicating flexibility
mainly in 4 loops.
doi:10.1371/journal.pone.0032336.g001
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Normal mode analysis (Figure S3) of the crystal structures
always indicated a very strong collective mode related to the
opening of the active-site cavity between the two lobes. The
structure of the CNPase catalytic domain in solution was studied
by small-angle X-ray scattering (SAXS), in order to observe
possible conformational changes. The catalytic domain was
monomeric under all employed conditions, with a very similar
overall shape to that in the crystal structure (Table 4, Figure 4).
Crystallization was only successful with sulphate or citrate present.
SAXS analysis in the presence of citrate also shows a compact
structure, very similar to the crystal structure; analysis of the
concentration dependency indicated that citrate reduced the
attractive forces between protein molecules (Figure S4). The result
explains the crystallization behaviour of CNPase. The fully active
overall conformation of CNPase in solution may, however, be
more open than that seen in crystal structures, as all the crystals
only grew in the presence of citrate or sulphate.
In full-length CNPase, the catalytic domain is followed by 22
C-terminal residues that contain the membrane anchoring site.
Figure 2. Details of the active site. (a) An overall view of the CNPase active site. The apparent 2-fold symmetry axis of the active site is indicated
by the green asterisk. The catalytic residues and 5 ordered water molecules are labelled. In this structure, the active site is occupied by a citrate
molecule. (b) Stereo view of the binding mode of 29-AMP to mouse CNPase. (c) Complex with NADP
+. The double conformation of the region around
Pro320 is also shown; the conformation in green corresponds to the one with the ligand, and the pink one to the conformation without bound
ligand. (d) CNPase complex with two sulphate molecules. One sulphate resides in the active site (left) and the other binds to the a6-b5 loop (right).
doi:10.1371/journal.pone.0032336.g002
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available, but it is unlikely that this tail is folded [12,31]. Our
SRCD studies indicated that a palmitoylated peptide compris-
ing the C-terminus is unfolded in membrane-mimicking
conditions [31]. We further studied the solution conformations
of extended versions of the catalytic domain by synchrotron
SAXS (Table 4, Figure 4C,D, Figure S4). The presence of the
C-terminal tail (construct cat-C) did not significantly affect the
conformation of the catalytic domain in solution. For the N-
terminally extended catalytic domain (N-cat), overall dimen-
sions remained similar, with an increased radius of gyration.
Only when both extensions were included (N-cat-C), did the
molecule become significantly more elongated. The result
highlights the short distance that must remain between the
active site and the membrane surface, to which the C-terminus
is anchored in vivo.
Table 3. CNPase structural homologs, for which experimental structures are available.
Protein Organism PDB id (reference) Active-site ligand Rmsd (# residues) Sequence identity (%)
CNPase Homo sapiens 1woj [11] Phosphate 0.8 (200) 81
CNPase* Rattus norvegicus 2ilx [5] - 2.2 (194) 85
RICH* Carassius auratus 2i3e [10] - 2.5 (187) 43
29-59 RNA ligase Thermos thermophilus HB8 1iuh [28] - 2.9 (106) 25
29-59 RNA ligase Pyrococcus horikoshii 1vgj [26] - 2.8 (106) 14
CPDase Arabidopsis thaliana 1fsi [29] Sulphate 3.2 (107) 14
29-59 RNA ligase* Pyrococcus furiosus 2fyh [27] - 3.0 (104) 14
Putative 29-59 RNA ligase Bacillus subtilis 2d4g (-) - 3.5 (104) 13
AKAP18 central domain Homo sapiens 2vfk,2vfl,2vfy [30] 59-AMP,-,59-CMP 3.2 (106) (2vfk) 10
ATU0111 (unknown function) Agrobacterium tumefaciens str. C58 2fsq (-) Acetate 3.1 (109) 16
*NMR.
doi:10.1371/journal.pone.0032336.t003
Figure 3. Comparisons to structures of 2H family members. (a) Superposition of the CNPase/RICH structures. Colouring: mouse, light blue;
human, green; rat, pink; goldfish RICH, gray. Note the conservation of the a7 helix in all structures; the 29-AMP from the mouse CNPase active site is
also shown. (b) Superposition of mouse CNPase (light blue) and human AKAP18 (orange), the two nucleotide-bound complexes of 2H family
members. The C-terminus and the a7 helix of CNPase are labelled, and the covering C-terminal loop of AKAP18, present in non-CNPase 2H family
members, is indicated by an arrow. The 29-AMP in CNPase is in blue and the 59-AMP in AKAP18 in magenta. Note that only the phosphate groups of
the nucleotide ligands overlap.
doi:10.1371/journal.pone.0032336.g003
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dimerization
During purification of full-length CNPase and the N-terminal
domain, a large peak is always observed at the void volume of the
size exclusion column. While we originally assumed the protein is
aggregated, further experiments showed that this peak contains
RNA bound to CNPase; the peak height can be significantly
decreased with RNase A (Figure 5A). Furthermore, RNase
treatment coupled with agarose gel electrophoresis showed the
void volume sample contained RNA (Figure 5B). The behaviour of
CNPase in these assays is highly similar to the uracil-DNA-
degrading factor [32]. No peak at the void volume is observed for
the catalytic domain (data not shown), which indicates the N-
terminal domain of CNPase is involved in RNA binding, at least in
the case of E. coli RNA. Previously, CNPase was shown to bind
RNA in vitro and be copurified with poly(A)+ RNA; the catalytic
domain was sufficient to bind single-stranded RNA homopolymers
in a pulldown assay [18]. We also carried out a similar pulldown
experiment with poly(A)-sepharose; the N-terminal domain bound
the matrix efficiently, while little binding was observed for the C-
terminal domain (Figure 5C).
If the terminus of an RNA molecule indeed acts as a CNPase
substrate, it will bind the surface from the active site towards the
N-terminal domain (Figure 5D). In 3D space, the N-terminal
domain will be a continuation of the catalytic domain small lobe.
A cluster of aromatic residues is found on the surface of the
catalytic domain in this area, forming a patch that leads towards
the N-terminal domain (Figure 5E). Furthermore, a positively
charged rim is present at the edge of this aromatic surface
(Figure 5D). Thus, the surface of the small lobe may provide a
Figure 4. Conformation of the CNPase catalytic domain as detected by SAXS. (a) Left: Experimental scattering curve for the CNPase
catalytic domain (red dots) overlaid with the theoretical scattering curve computed using the crystal structure (black line). The Guinier plot
corresponding to this scattering curve is shown in Figure S4. Middle: Distance distribution function. Right: Averaged ab initio model of the
phosphodiesterase domain (white surface) superimposed with the crystal structure (magenta). (b) SAXS analysis of extended CNPase catalytic domain
constructs – left: scattering curves, middle: distance distribution functions. Black: the crystallized catalytic domain; red: construct cat-C; blue: construct
N-cat; green: construct N-cat-C. The scattering curves are slightly displaced in the y direction for easier viewing: the corresponding Guinier plots are
shown in Figure S4. Right: Ab initio models of the catalytic domain (gray), cat-C (pink), N-cat (blue), and N-cat-C (green). The results indicate that the
N- and C-terminal extentions alone affect the structure little, while an extended tail is formed when both of them are present.
doi:10.1371/journal.pone.0032336.g004
Table 4. Active-site ligand-dependent solution properties of
the CNPase catalytic domain, as determined by SAXS.
Sample Dmax (nm) Rg (nm) Volume (nm
3) I(0) (relative)
CNPase 6.8 2.06 48.2 19.7
Crystal structure
envelope*
6.8 1.84 30.8 -
Catalytic
# 7.1 2.13 44.4
cat-C 6.8 2.09 46.0
N-cat 7.0 2.20 48.3
N-cat-C 8.6 2.42 52.2
*as calculated using CRYSOL [60].
#samples starting from this line were measured at a different beamline.
doi:10.1371/journal.pone.0032336.t004
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N-terminal domain may be required for high-affinity binding.
Further studies will be required to elucidate the details of RNA
binding by CNPase.
The tendency of self-association by full-length CNPase was also
observed. As shown by a combination of size exclusion
chromatography and multi-angle light scattering (SEC/MALS),
the full-length protein is present as monomers, dimers, and high-
molecular weight species (Figure 6A). The CNPase N-terminal
domain alone elutes as a dimer on gel filtration (Figure 6B). These
data strongly suggest a role for the N-terminal domain in the
mediation of dimerization of full-length CNPase. No 3D structural
data are available to date on full-length CNPase. The identifica-
tion of the N-terminal domain as a self-association domain
provides a valid explanation for early observations of putative
CNPase dimers [33,34].
The CNPase reaction mechanism
While the crystal structure of the human CNPase phosphodi-
esterase domain with bound phosphate [11] has enabled theories
on the exact mechanism, the lack of substrate or product
complexes has left uncertainties about the details of substrate/
product binding. The mechanism is related to the well-
characterized reaction mechanism of RNase A in its second half-
reaction, where the RNA 29,39-cyclic end is processed to form 39-
phosphate. Mutagenesis indicated different roles for the active-site
residues in CNPase; the His residues were critical for catalysis, but
not substrate binding. Thr311 is more important for catalysis than
Thr232, which plays a larger role in substrate binding [5]. The
CNPase optimum pH (around 6) is likely to be related to the pKa
values of the catalytic His residues. Our data, showing for the first
time the binding mode of a physiologically relevant reaction
product, now clarify the active-site geometry and interactions
when nucleotide ligands are bound (Figure 7A,B). His309,
oriented by the carbonyl oxygen of Arg307, activates a water
molecule, which performs a nucleophilic attack on the cyclic
phosphate. The pentavalent phosphate intermediate is stabilized
by the protonated His230 binding to the leaving O39-group
oxygen, and the Thr residues and active-site waters coordinating
the ‘free’ oxygens of the phosphate. His230 then protonates the
Figure 5. RNA binding. (a) Elution profiles of purified full-length CNPase with (blue) and without (red) RNase A treatment. (b) Gel electrophoresis of
fractions from size exclusion chromatography. Top: SDS-PAGE analysis of the void volume (1) and the monomer peak (2). Middle: The same samples
run on an agarose gel with ethidium bromide staining. Bottom: A sample from the void volume with (+) and without (2) RNase treatment confirms
the presence of RNA. (c) Binding of different CNPase constructs to a polyadenylyl affinity matrix. 1 – input sample; 2–6 – washes; 7 – bound protein
eluted from the matrix with sample buffer. FL – full-length; C – catalytic domain; N – N-terminal domain. (d) The potential beginning of the RNA-
binding site in CNPase. The large hydrophobic surface extends from the active site towards the N-terminal domain. The hydrophobic region is
surrounded by a rim of positive electrostatic potential. The colouring is from 20.3 V (red) to +0.3 V (blue), as implemented in ccp4mg [51]. The
magenta arrow indicates the suggested binding surface for RNA. The N- and C-termini for the domain are labeled. (e) Stereo view of the aromatic
cluster in the small lobe.
doi:10.1371/journal.pone.0032336.g005
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e32336Figure 6. Dimerization is possibly mediated by the N-terminal domain. (a) SEC/MALS indicates monomer-dimer equilibrium for full-length
CNPase. The calculated molecular masses (black) for the two peaks are 78 and 44 kDa, based on light scattering and refractive index. Higher-order
oligomers are also detectable. (b) Analysis of the purified N-terminal domain by SEC indicates the presence of dimers. The elution volumes of
molecular weight standards run on the same column are indicated above the graph (in kDa). The expected monomeric molecular weight is 19 kDa,
and the elution volume is compatible with the presence of a slightly elongated dimer.
doi:10.1371/journal.pone.0032336.g006
Figure 7. CNPase reaction mechanism, as supported by the structural data. (a) The reaction mechanism, including the H-bonding
interactions in the active site. (b) Stereo view of the interactions during the reaction in the active site. Dashed lines indicate the polar interactions
before (magenta) and after (green) the reaction. The black dashed line indicates the nucleophilic attack by water 5. While the product 29-AMP (light
blue) is from the crystal structure, the substrate 29,39-cAMP (white) was modeled into the active site by docking.
doi:10.1371/journal.pone.0032336.g007
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contacts between the ligand and the active-site residues, including
conserved water molecules, remain throughout the reaction
(Figure 7A,B).
Concluding remarks
We have now provided a long-sought high-resolution view into
the liganded CNPase active site, which enables a better
understanding of substrate binding and the catalytic mechanism.
We also showed that the N-terminal domain mediates self-
association of CNPase, and may function as an extended RNA-
binding site. Conformational changes may be of importance in the
CNPase catalytic cycle. The links between CNPase binding to its
different ligands, its oligomeric status, and its phosphodiesterase
activity still remain to be clarified. A major goal for future research
will be the high-resolution structure determination of full-length
CNPase.
Materials and Methods
Protein expression and purification
CNPase has 400 (CNP1) or 420 (CNP2) amino acid residues.
The catalytic domain (residues 159–378; numbering for the CNP1
isoform) and the full-length (residues 21–378) CNPase constructs,
lacking the 22-residue C-terminal tail, were overexpressed and
purified as described [35]. For SAXS studies on the effects of
extensions on the catalytic domain structure, 3 more constructs
were used: N-cat (residues 138–378), cat-C (residues 159–400),
and N-cat-C (residues 138–400). Briefly, mouse CNPase cDNA
was cloned into the pTH27 expression vector [36], overexpressed
in E.coli, and purified using nickel affinity and size exclusion
chromatography, and the His-tag was removed. The phosphodi-
esterase activity and proper folding of the enzyme were also
verified [35]. Molecular weights of full-length CNPase were
determined using SEC/MALS. For the latter, an online system
consisting of the A ¨kta Purifier (GE Healthcare), a size exclusion
column (Sephadex S-200; GE Healthcare), the miniDAWN
TREOS light scattering detector (Wyatt), and the Optilab rEX
refractive index detector (Wyatt) was used; data analysis was
performed with the Astra software (Wyatt). The running buffer
was 20 mM Bis-Tris-HCl pH 5.5, 300 mM NaCl, 1% glycerol,
and 1 mM DTT.
For the expression of the N-terminal domain of murine
CNPase, an optimized protocol was developed. The CNPase
residues 21–160 [35] were cloned into the pHMGWA expression
plasmid using Gateway cloning [37]. Protein was expressed in
Rosetta (DE3) cells (Novagen), with a 48-h expression at +20uCi n
ZYM-5052 autoinduction medium [38]. Initial purification was
done using Amylose resin (NEB) in 50 mM Tris-HCl pH 9, 0.5 M
NaCl, 10% (v/v) glycerol, and 1 mM DTT. The fusion protein
was eluted with the same buffer containing 10 mM D-maltose.
The maltose binding protein fusion was cleaved from CNPase by
TEV protease [39]; TEV and the tag were separated from
CNPase using a His-Trap Ni column (GE Healthcare) with the
same buffers as above, except that the elution buffer contained
0.5 M imidazole instead of maltose. The final purification step was
SEC with a Superdex 75 16/60 column (GE Healthcare) in a
running buffer containing 10 mM CAPS pH 10, 0.2 M NaCl, and
1 mM DTT.
SEC analysis of the purified CNPase N-terminal domain was
done using the Duoflow chromatography system (Bio-Rad) and a
Superdex 75 10/300 GL column (GE Healthcare), in a running
buffer containing 20 mM Na-HEPES pH 8, 200 mM NaCl, and
1 mM DTT. 250 ml of the N-terminal domain at 1.7 mg/ml were
injected into the column; molecular weight markers were run
under the same conditions.
X-ray crystallography and structure analysis
For crystallization, the mouse CNPase catalytic domain was
dialyzed into a buffer containing 10 mM sodium citrate pH 5.5,
50 mM NaCl, 10% glycerol, and 1 mM DTT. The detailed
crystallization, soaking, and cryoprotection conditions are in
Table 1. X-ray diffraction data were collected at synchrotron
radiation beamlines BL14.1 (BESSY, Berlin) and I911-2 (MAX-
Lab, Lund), at 100 K. Data were processed and scaled using XDS
[40] and XDSi [41]. Molecular replacement was done using
MOLREP [42] or PHASER [43]. The initial molecular
replacement model was the catalytic domain of human CNPase
[11]. Later on, the best refined coordinates of mouse CNPase were
always used. Structures were refined using PHENIX [44] or
REFMAC [45], and models were built using Coot [46]. Simulated
annealing omit maps in the absence of bound ligand were
calculated in PHENIX. Processing and refinement statistics, as
well as PDB accession numbers, are in Table 2.
The Molprobity server [47] was used for validation. Normal
modes were calculated using the elastic network model [48].
Structural homologs were detected using PDBeFold [49] and
Salami [50], and superpositions and structure analysis were
carried out in Coot, ccp4mg [51], and PyMOL (http://www.
pymol.org).
Modeling
The molecular docking studies of ligands were performed with
the crystal structure of CNPase. The product and water molecules
in the PDB file were removed before the docking simulations.
However, crucial water molecules forming hydrogen bonds with
the product in the crystal structure were retained. The structures
of docked ligands were obtained from the PDB and modified if
necessary. The docking studies were performed with AutoDock
Vina [52], with the aid of the AutoDock Tools interface. The side
chains of several residues in the binding pocket of CNPase were set
to be flexible. All rotatable bonds in the ligands were allowed to
rotate freely. The grid map was centered on the binding pocket of
the protein, and its size was set to 21614618 A ˚. The results were
analyzed using PyMOL, and the final results were selected based
on the binding modes [52].
Small-angle X-ray scattering
All samples used for SAXS eluted from size exclusion
chromatography as single symmetric peaks, corresponding to
monomeric forms of the CNPase catalytic domain (see [35]).
Initial synchrotron SAXS data were collected on the EMBL
beamline 633 at DESY, Hamburg, Germany. The CNPase
catalytic domain was first transferred by size exclusion chroma-
tography into a buffer containing 50 mM Bis-Tris-HCl pH 5.5,
100 mM NaCl, 3% glycerol, and 1 mM DTT. SAXS data were
measured at 5–15 mg/ml. For analyzing the effects of citrate on
the protein, SAXS data were collected on the ID14-3 beamline at
ESRF, Grenoble. The buffer consisted of 20 mM Bis-Tris
(pH 5.5), 300 mM NaCl, 1% glycerol, 1 mM TCEP, and
concentrations between 1–10 mg/ml were used. Data were
measured in the presence and absence of 50 mM sodium citrate.
The comparison of the catalytic domain with N- and C-terminal
extensions was carried out on the P12 EMBL BioSAXS beamline
(PETRA III, DESY, Hamburg). The samples were in 20 mM Bis-
Tris (pH 5.5), 200 mM NaCl, 1 mM TCEP. Sample concentra-
tions ranged between 3 and 15 mg/ml.
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described [54,55]. PRIMUS was used for processing [56], GNOM
for distance distribution evaluation [57], DAMMIN for ab initio
model building [58], and DAMAVER for model averaging [59].
Detection of bound RNA
For observing bound RNA, carried over from the expression
host during affinity purification, agarose gel electrophoresis of gel
filtration fractions was carried out with ethidium bromide staining.
Control samples were treated with RNase A prior to electropho-
resis. Purified CNPase was also subjected to RNase A treatment,
followed by gel filtration on a Sephadex S-75 column (in 0.1 M
sodium phosphate, 0.1 M sodium citrate, 1 M NaCl, 10%
glycerol, 50 mM (NH4)2SO4, 1 mM DTT, pH 5.5).
Polyadenylyl sepharose matrix was prepared using CNBr-
activated Sepharose 4B and polyadenylic acid (GE Healthcare),
according to the protocol provided by the manufacturer. Prior to
the binding assay, the matrix was equilibrated with binding buffer
(10 mM Tris-HCl pH 7.5, 50 mM NaCl, 2.5 mM MgCl2,1m M
DTT), adapted from [18]. The binding of various CNPase
constructs to the poly(A) matrix was carried out as follows.
Approximately 250 mg of each protein in a volume of 0.5 ml (in
binding buffer) were mixed with 50 ml of the affinity matrix for 2 h
at +4uC. The matrix was collected by centrifugation, and washed 5
consecutive times with 0.5 ml of binding buffer. Thereafter, bound
proteins from the matrix, resuspended in 100 ml of binding buffer,
were eluted with SDS-PAGE sample buffer and analyzed by SDS-
PAGE and Coomassie staining.
Supporting Information
Figure S1 Stereo views of electron densities for the
active-site nucleotide ligands. Top: 29-AMP; bottom:
NADP
+. The final refined 2Fo-Fc maps (light blue) are contoured
at 1.2 s for 29-AMP and 1 s for NADP
+. Simulated annealing
omit maps (black) are also shown at 2.5 s.
(TIF)
Figure S2 Structure-based sequence alignment of
mouse CNPase with other known structures from the
2H family. Group 1 contains CNPases and RICH, and group 2
more distant homologues. The HxTx motifs are indicated by
green asterisks below the alignment. The secondary structure
elements are those seen in mouse CNPase (see also Figure 1).
(TIF)
Figure S3 A major normal mode for the CNPase
catalytic domain, corresponding to an open/close
movement of the catalytic cleft between the two lobes.
The conformation in the crystal structure is in red, the most open
conformation in magenta, and the most closed in blue.
(TIF)
Figure S4 Lack of aggregation in the samples and
concentration dependency of SAXS measurement. The
figures on the left show the Guinier plots, indicating no
aggregation, while the figures on the right show the behaviour of
the samples as a function of protein concentration. (a) Comparison
of the CNPase catalytic domain in the presence (filled symbols)
and absence (open symbols) of citrate. For the concentration
dependence, radii of gyration are indicated in black and forward
scattering intensities in red. (b) Analysis of N- and C-terminal
extensions to the CNPase catalytic domain. Colouring as in
Fig. 4B.
(TIF)
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